1. Home
  2. STG vs HLVX Comparison

STG vs HLVX Comparison

Compare STG & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STG
  • HLVX
  • Stock Information
  • Founded
  • STG 2003
  • HLVX 2020
  • Country
  • STG China
  • HLVX United States
  • Employees
  • STG N/A
  • HLVX N/A
  • Industry
  • STG Other Consumer Services
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • STG Real Estate
  • HLVX Health Care
  • Exchange
  • STG Nasdaq
  • HLVX Nasdaq
  • Market Cap
  • STG 91.6M
  • HLVX 92.6M
  • IPO Year
  • STG 2018
  • HLVX 2022
  • Fundamental
  • Price
  • STG $6.57
  • HLVX $1.88
  • Analyst Decision
  • STG
  • HLVX Hold
  • Analyst Count
  • STG 0
  • HLVX 5
  • Target Price
  • STG N/A
  • HLVX $2.33
  • AVG Volume (30 Days)
  • STG 9.1K
  • HLVX 175.9K
  • Earning Date
  • STG 03-21-2025
  • HLVX 03-19-2025
  • Dividend Yield
  • STG N/A
  • HLVX N/A
  • EPS Growth
  • STG N/A
  • HLVX N/A
  • EPS
  • STG 4.57
  • HLVX N/A
  • Revenue
  • STG $292,030,936.00
  • HLVX N/A
  • Revenue This Year
  • STG N/A
  • HLVX N/A
  • Revenue Next Year
  • STG N/A
  • HLVX N/A
  • P/E Ratio
  • STG $1.42
  • HLVX N/A
  • Revenue Growth
  • STG N/A
  • HLVX N/A
  • 52 Week Low
  • STG $4.25
  • HLVX $1.55
  • 52 Week High
  • STG $12.55
  • HLVX $20.22
  • Technical
  • Relative Strength Index (RSI)
  • STG 51.44
  • HLVX 48.11
  • Support Level
  • STG $6.52
  • HLVX $1.67
  • Resistance Level
  • STG $6.92
  • HLVX $1.99
  • Average True Range (ATR)
  • STG 0.15
  • HLVX 0.08
  • MACD
  • STG -0.03
  • HLVX -0.00
  • Stochastic Oscillator
  • STG 44.72
  • HLVX 57.38

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: